Understanding how T cell receptors recognize different peptides
Revealing the Structural Determinants of TCR Cross-Recognition via Extended Positional Scanning
This study is looking at how T cells, which are important for fighting diseases like cancer and autoimmune disorders, recognize different pieces of proteins, and it aims to make T cell treatments safer and more effective for patients like you.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Notre Dame NIH-funded |
| Lab location | 1 site (Notre Dame, United States) |
| Project ID | NIH-11165449 on NIH RePORTER |
What this research studies
This research investigates how T cell receptors (TCRs) interact with various peptide antigens presented by major histocompatibility complex (MHC) proteins. By analyzing the structural determinants that influence TCR cross-recognition, the study aims to improve the safety and efficacy of T cell therapies for conditions like cancer and autoimmune diseases. The approach involves advanced techniques to predict TCR behavior and assess the range of peptides they can respond to, which is crucial for developing targeted therapies. Patients may benefit from more precise and safer T cell therapies as a result of this research.
Who could benefit from this research
Good fit: Ideal candidates include patients with conditions that could benefit from T cell therapies, such as cancer, viral infections, or autoimmune disorders.
Not a fit: Patients who do not have conditions amenable to T cell therapy may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective T cell therapies for various diseases.
How similar studies have performed: Previous research has shown promise in improving T cell therapies, but this approach aims to address specific limitations in current predictive methods, making it a novel endeavor.
Where this research is happening
Notre Dame, United States
- University of Notre Dame — Notre Dame, United States (Active)
Researchers
- Principal investigator: Brambley, Chad — University of Notre Dame
- Study coordinator: Brambley, Chad
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.